药物监督敏感化对高等医疗教学医院中医学和准医学学生的知识和态度的影响:基于问卷的研究
Vaishali Thakare1, Mukta Jain2, Masum Reza1
1Pharmacology, DY Patil University School of Medicine, Navi Mumbai, IND.
Cureus
|November 10, 2025
概括
药物监测敏感化会议显著改善了医疗保健学生对药物不良反应 (ADR) 报告的知识和态度. 早期意识和培训对于提高药物安全性和鼓励积极参与ADR报告计划至关重要.
科学领域:
- 药监和药物安全 药监和药物安全
- 医学教育 医学教育
- 公共卫生 公共卫生
背景情况:
- 药物不良反应 (ADRs) 是全球严重的健康负担,导致发病率和死亡率.
- 报道不充分的不良反应妨碍了有效的药物安全监测.
- 医疗保健学生对药物监测的早期敏感化对于改善ADR报告率至关重要.
研究的目的:
- 评估药物监督宣传会对医学和护理学生的知识和态度的影响.
- 评估对理解药监术语和ADR报告程序的改进.
- 促进未来医疗保健专业人员积极参与ADR报告.
主要方法:
- 采用了前后干预研究设计.
- 对参与者进行了验证的知识态度调查问卷.
- 在国家药物监督周期间,从医学,阿育吠陀和护理学生那里收集了数据.
主要成果:
- 干预后,医疗和护理学生在识别药监术语和ADR报告表格方面显著改善.
- 医学学生最初表现出更高的关于ADR报告和表格的预测知识.
- 对于药物监测和ADR报告的态度也得到了改善,医学学生表现得越来越积极.
结论:
- 药物监督宣传会有效地提高了未来医疗保健提供者对ADR报告的知识和态度.
- 建议定期进行干预,以保持意识并促进一致的报告实践.
- 在本科课程中加强药监教育对于改善全球药物安全至关重要.
相关概念视频
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Bioavailability Study Design: Healthy Subjects Versus Patients
137
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
137
Desensitization and Tachyphylaxis
3.0K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
392
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
392
Factors Affecting Drug Response: Overview
2.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.9K
Dosage Regimens: Partial Pharmacokinetic Parameters
141
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
141


